Phospho-VCL (Tyr822) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Form
Rabbit IgG in phosphate-buffered saline (PBS) without Mg²⁺ and Ca²⁺, pH 7.4, containing 150 mM NaCl, 0.02% sodium azide, and 50% glycerol.
Lead Time
Orders are typically dispatched within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Synonyms
CMD1W antibody; CMH15 antibody; Epididymis luminal protein 114 antibody; HEL114 antibody; Metavinculin antibody; MV antibody; MVCL antibody; OTTHUMP00000019861 antibody; OTTHUMP00000019862 antibody; VCL antibody; VINC antibody; VINC_HUMAN antibody; Vinculin antibody
Target Names
VCL
Uniprot No.

Target Background

Function

Vinculin is an actin filament (F-actin)-binding protein crucial for cell-matrix and cell-cell adhesion. It regulates cell-surface E-cadherin expression and enhances mechanosensing by the E-cadherin complex. Vinculin also plays significant roles in cell morphology and motility.

Gene References Into Functions

Vinculin's diverse functions are supported by extensive research, highlighted in the following publications:

  • Vinculin's role in maintaining glomerular filtration barrier integrity by modulating podocyte foot processes and stabilizing intercellular junctions. PMID: 29241625
  • ERα upregulates vinculin expression in breast cancer cells; vinculin loss promotes amoeboid cancer cell characteristics. PMID: 28266545
  • Polyoma small T antigen upregulates tubulin and vinculin expression in a time-dependent manner, with tubulin exhibiting the most significant change. PMID: 29104053
  • Differential phosphatidylinositol 4,5-diphosphate binding to vinculin isoforms promotes quasi-equivalent dimerization. PMID: 27503891
  • An all-heavy-atom structure-based model revealed that vinculin activation by talin under high tension (mechanically driven by F-actin) proceeds through an intermediate state stabilized by partial talin-vinculin association, with distinct low- and high-force activation pathways. PMID: 29045864
  • Vinculin head-tail interaction is crucial on soft substrates for destabilizing vinculin and talin in focal adhesions (FAs) and enabling human mesenchymal stem cell (hMSC) branching. A separate module involving paxillin and FAK is also destabilized on soft substrates, independently of vinculin head-tail interaction. This multi-modular system allows versatile responses to complex biomechanical cues. PMID: 27169142
  • The critical roles of talin and vinculin in cell adhesions suggest that tissue disintegration in atherosclerosis may partly result from downregulation of these genes, leading to weakened cell-extracellular matrix (ECM) interactions and tissue remodeling. PMID: 27816808
  • The East Asian common VCL variant p.Asp841His (D841H) is associated with sudden unexplained nocturnal death syndrome (SUNDS) in the Chinese Han population. PMID: 28373245
  • Mutations in VCL are linked to short-segment Hirschsprung disease. CRISPR/Cas9-mediated correction of this mutation, along with the RET G731del mutation causing total colonic aganglionosis, restored enteric neural crest cell function in induced pluripotent stem cells. PMID: 28342760
  • This review comprehensively discusses vinculin's roles in cell-cell and cell-matrix adhesions, focusing on its recruitment, activation, and regulation. PMID: 28401269
  • A combined flexible docking and molecular dynamics simulation predicted the structure of the MAPK1-vinculin binding interface. This interaction is mechanically regulated, with a change in vinculin D3-D4 cleft size upon activation underlying the conformational selectivity of MAPK1 binding to open vinculin. PMID: 28494959
  • Vinculin promotes nuclear localization of the transcription factor TAZ to inhibit adipocyte differentiation on rigid ECM. PMID: 28115535
  • VCL (the gene encoding vinculin) is implicated in cardiomyopathy associated with hypertension; rs4746172 of VCL may be a target for clinical interventions to reduce cardiovascular disease (CVD) risk by regulating blood pressure in males of Chinese descent. PMID: 26487440
  • Three genes (MYCN, MYO5B, and VCL) were identified as recurrently mutated in malignant sympathetic paraganglioma tumors. PMID: 26650627
  • This study explores the roles and mechanisms of phospholipids in regulating the structure and function of vinculin and its muscle-specific metavinculin splice variant. PMID: 26728462
  • Upon actin engagement, the N-terminal "strap" and helix 1 displace from the vinculin tail helical bundle to mediate actin bundling. PMID: 26493222
  • This study demonstrates a dynamic relationship between vinculin-mediated tension and adhesion complex area, which controls fundamental cell-matrix adhesion properties. PMID: 26109125
  • ITGB4 and VCL are upregulated in exosomes from taxane-resistant prostate cancer cells, suggesting their utility as markers for taxane-resistance associated prostate cancer progression. PMID: 25997717
  • Vinculin is identified as an autoantigen targeted by anti-citrullinated protein antibody (ACPA) and CD4⁺ T cells in the joints of ACPA⁺ rheumatoid arthritis patients. PMID: 25942574
  • Stretched talin activates vinculin, inducing positive feedback that strengthens actin-talin-vinculin association. PMID: 24452080
  • Specific protein interactions are spatially segregated within focal adhesions (FAs) at the nanoscale to regulate vinculin activation and function. PMID: 26053221
  • Vinculin expression is significantly downregulated. PMID: 25496021
  • NMR and ITC data show that the SH3a and SH3b domains of CAP simultaneously bind to a long proline-rich region of vinculin with distinct binding specificities. PMID: 24878663
  • PIP2 binding is essential for controlling vinculin dynamics and turnover in focal adhesions. PMID: 25488920
  • Vinculin is a potential plasma biomarker for age-related macular degeneration. PMID: 25298412
  • Vinculin negatively regulates the malignant phenotype of tumor cells, including MT1-MMP transcription, via the MEK/ERK pathway. PMID: 25449281
  • Vinculin is a novel marker for atherosclerosis. PMID: 24369271
  • Vinculin induces talin-mediated integrin activation. PMID: 24446374
  • Vinculin binds to Rab5 and is required for Staphylococcus aureus uptake in cells. PMID: 24466349
  • Case report: VCL-ALK gene fusion in renal cell carcinoma in a patient with sickle cell trait. PMID: 24698962
  • Vinculin Y822 phosphorylation regulates whether cadherins transmit force, providing a model for how a shared adhesion component can produce distinct biological functions. PMID: 24751539
  • p38 mitogen-activated protein kinase interacts with vinculin at focal adhesions during fatty acid-stimulated cell adhesion. PMID: 24219282
  • Mechanical forces applied to focal adhesions (FAs) facilitate vinculin binding to talin at FAs. PMID: 24452377
  • This study elucidated how tensile forces from single stress fibers are distributed temporally and spatially to vinculin mechanosensors within cell-matrix adhesions. PMID: 23687380
  • Lasp-2 interacts with the focal adhesion proteins vinculin and paxillin. PMID: 23389630
  • VAX1 rs10787760, rs6585429, and rs1871345 polymorphisms may be involved in nonsyndromic cleft lip with or without cleft palate in Brazilian patients, but no association was found with polymorphisms in FGF12, VCL, or CX43. PMID: 23679094
  • Vinculin protein levels are significantly higher in SW620 cells compared to SW480 cells. PMID: 23627409
  • Vinculin bundles actin filaments, caps these filaments, and promotes actin polymerization. PMID: 23466368
  • Metavinculin enrichment in muscle cell attachment sites enhances the mechanical stability of adhesion complexes, increasing shear force resistance. PMID: 23159629
  • Vinculin is predominantly expressed in pancreatic cancer tissues compared to non-cancerous tissues, suggesting its potential as a clinical biomarker for pancreatic cancer. PMID: 22940724
  • Raver1 forms a ternary complex with metavinculin and vinculin mRNA. PMID: 22709580
  • Metavinculin efficiently severs actin filaments, even at substoichiometric concentrations. PMID: 22613835
  • Vinculin must be activated to bind alpha-catenin; this interaction is stabilized by a ternary alpha-catenin-vinculin-F-actin complex formed via the F-actin binding domain. PMID: 22493458
  • Vinculin-dependent VE-cadherin mechanosensing is involved in endothelial processes like leukocyte extravasation and angiogenesis. PMID: 22391038
  • SGK1 regulates cell migration through vinculin dephosphorylation, a mechanism controlled by membrane androgen receptor function. PMID: 22309306
  • Alpha-catenin activates vinculin through a novel mechanism, potentially explaining differential vinculin recruitment/activation in cell-cell and cell-matrix adhesions. PMID: 22235119
  • Sca4 activates vinculin and interacts with the actin cytoskeleton; vinculin plays roles in Rickettsia pathogenesis. PMID: 21841197
  • VCL expression differs in benign prostatic hyperplasia and prostate cancer, potentially serving as a diagnostic indicator. PMID: 21171262
  • Inhibition of myosin II contractility alters the dissociation kinetics of vinculin, paxillin, and zyxin from focal adhesions. PMID: 21486952
  • Talin-1 and vinculin negatively affect paxillin tyrosine phosphorylation (a positive regulator of HIV-1 infection), inhibiting infection by distinct retroviruses. PMID: 21763488
Database Links

HGNC: 12665

OMIM: 193065

KEGG: hsa:7414

STRING: 9606.ENSP00000211998

UniGene: Hs.643896

Involvement In Disease
Cardiomyopathy, dilated 1W (CMD1W); Cardiomyopathy, familial hypertrophic 15 (CMH15)
Protein Families
Vinculin/alpha-catenin family
Subcellular Location
Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, adherens junction. Cell junction, focal adhesion. Cytoplasm, cytoskeleton. Cell membrane, sarcolemma; Peripheral membrane protein; Cytoplasmic side.
Tissue Specificity
Metavinculin is muscle-specific.

Q&A

What is the biological significance of vinculin Tyr822 phosphorylation in cellular adhesion?

Vinculin Tyr822 phosphorylation serves as a critical regulator of force transmission at cellular adhesions. This specific phosphorylation site plays a fundamental role in modulating vinculin's interactions with other focal adhesion proteins. Research indicates that Tyr822 phosphorylation significantly impacts cell-cell adhesions by regulating force transmission between adjacent cells . Unlike other phosphorylation sites such as Ser721, which affects vascular endothelial junctions and atherosclerosis progression, Tyr822 appears more directly involved in regulating the dynamic interactions within focal adhesion complexes . The phosphorylation status of this residue can dramatically alter cellular behavior, with phosphorylation affecting protein-protein interactions and mechanical force sensing capabilities.

How does vinculin Tyr822 compare with other functionally important phosphorylation sites?

Vinculin contains multiple phosphorylation sites that serve distinct functions in regulating its activity and interactions:

Phosphorylation SitePrimary FunctionCellular ImpactAssociated Pathways
Tyr822Force transmission at cell-cell adhesionsRegulates focal adhesion size and dynamicsCellular mechanotransduction
Ser721Endothelial junction stabilityIncreases endothelial permeability when phosphorylatedAtherosclerosis progression
Y397 (FAK)Vinculin activation partnerPromotes focal adhesion dynamicsFAK-paxillin signaling pathway

Unlike Ser721 phosphorylation, which is primarily associated with endothelial cell function and vascular disorders, Tyr822 phosphorylation appears to have broader implications for cellular adhesion and migration across multiple cell types . Additionally, while FAK phosphorylation at Y397 regulates focal adhesion dynamics through paxillin phosphorylation, Tyr822 phosphorylation on vinculin more directly affects its ligand-binding properties .

What techniques are most effective for detecting phosphorylated vinculin Tyr822?

Detection of phosphorylated vinculin at Tyr822 requires specific methodological approaches for optimal results:

  • Western Blotting: Using phospho-specific antibodies at a 1:2000 dilution with appropriate blocking conditions (5% BSA in TBST rather than milk, which contains phosphatases) . Samples must be prepared with phosphatase inhibitors to preserve phosphorylation status.

  • Immunoprecipitation: Employing phospho-tyrosine antibodies (1:50 dilution) to pull down phosphorylated proteins followed by vinculin-specific detection, or vice versa .

  • Immunofluorescence: Utilizing phospho-specific antibodies with paraformaldehyde fixation (avoid methanol which can disrupt phospho-epitopes) to visualize localization of phosphorylated vinculin within focal adhesions.

  • Proximity Ligation Assay (PLA): This technique can detect the proximity between vinculin and its binding partners, allowing researchers to determine how Tyr822 phosphorylation affects these interactions in situ .

To confirm antibody specificity, appropriate controls should include phosphatase treatment of samples and use of phospho-deficient mutants (Y822F) as negative controls .

How does mutation of Tyr822 affect vinculin's function in focal adhesion dynamics?

Mutation studies of vinculin Tyr822 reveal profound effects on focal adhesion structure and dynamics:

The Y822F phospho-deficient mutation leads to dramatic alterations in cellular phenotype characterized by:

  • Highly spread cellular morphology

  • Significantly larger focal adhesions compared to wild-type vinculin

  • Increased cellular contractility

  • Enhanced talin recruitment to adhesion sites

  • Greater binding affinity to talin (though approximately 390-fold less than the constitutively active T12 vinculin variant)

In contrast, the Y822C mutation (observed in uterine cancer) produces opposite effects:

  • Increased cellular proliferation rates

  • Enhanced migration capability

  • Smaller focal adhesions compared to wild-type vinculin

  • Potentially reduced force transmission at adhesion sites

Interestingly, the Y822Q mutation, which maintains the hydrophilic character and potential hydrogen bonding capabilities of tyrosine, demonstrates binding to talin at levels comparable to Y822F but different from wild-type vinculin . This suggests that the specific chemical properties of this residue, beyond just phosphorylation potential, are critical for modulating vinculin's interactions within the focal adhesion complex.

What is the relationship between vinculin Tyr822 phosphorylation and mechanotransduction?

Vinculin Tyr822 phosphorylation functions as a molecular switch in mechanotransduction pathways by:

  • Regulating force transmission: Phosphorylation status affects vinculin's ability to transmit mechanical force between the cytoskeleton and adhesion complexes, particularly at cell-cell junctions .

  • Modulating protein interactions: Tyr822 phosphorylation alters vinculin's interaction with binding partners such as talin, paxillin, and actin filaments, thereby affecting the recruitment and retention of these proteins at focal adhesions .

  • Influencing conformational changes: The phosphorylation likely affects the head-tail interaction of vinculin, influencing its activation state and accessibility to binding partners. This is evidenced by differences in talin binding between wild-type and Y822F mutants .

  • Coordinating with other focal adhesion proteins: Vinculin functions within a complex network including BNIP-2, which serves as a scaffold protein coordinating FAK, paxillin, and vinculin within focal adhesion complexes . Tyr822 phosphorylation may influence these scaffolding interactions.

When investigating mechanotransduction, researchers should consider applying defined mechanical stimuli (such as substrate stiffness variation or direct force application) while monitoring Tyr822 phosphorylation status to establish causative relationships.

How can phospho-specific antibodies against vinculin Tyr822 be validated for research applications?

Rigorous validation of phospho-specific antibodies against vinculin Tyr822 should include:

  • Phosphatase treatment controls: Samples should be divided and one portion treated with lambda phosphatase to demonstrate antibody specificity for the phosphorylated form .

  • Mutant protein controls: Expression of phospho-deficient (Y822F) and phospho-mimetic mutants to verify antibody recognition patterns .

  • Peptide competition assays: Pre-incubation of the antibody with phosphorylated and non-phosphorylated peptides containing the Tyr822 sequence to confirm epitope specificity.

  • Cross-reactivity assessment: Testing across multiple species and against other phospho-tyrosine sites to ensure specificity for vinculin Tyr822 .

  • Stimulus-response validation: Treating cells with tyrosine phosphatase inhibitors (e.g., pervanadate) or growth factors known to induce tyrosine phosphorylation, then verifying increased antibody signal .

  • Multiple technique confirmation: Validating findings across Western blotting, immunoprecipitation, and immunofluorescence techniques to ensure consistent results .

  • Mass spectrometry correlation: For ultimate validation, correlation of antibody detection with mass spectrometry identification of the phosphorylated Tyr822 peptide from the same samples.

What are optimal protocols for using phospho-VCL (Tyr822) antibodies in different experimental techniques?

Western Blotting Protocol:

  • Lyse cells in RIPA buffer supplemented with protease inhibitors and phosphatase inhibitors (10 mM sodium fluoride, 1 mM sodium orthovanadate, 10 mM β-glycerophosphate).

  • Separate proteins on 7.5% SDS-PAGE gels to properly resolve vinculin (~117 kDa).

  • Transfer to PVDF membrane (preferred over nitrocellulose for phospho-proteins).

  • Block in 5% BSA in TBST (avoid milk due to phosphatase activity).

  • Incubate with phospho-VCL (Tyr822) antibody at 1:2000 dilution overnight at 4°C .

  • Wash extensively with TBST (5 × 5 minutes).

  • Incubate with appropriate HRP-conjugated secondary antibody.

  • Develop using enhanced chemiluminescence with extended exposure times if necessary.

Immunoprecipitation Protocol:

  • Prepare cell lysates as for Western blotting.

  • Pre-clear lysate with protein A/G beads.

  • Incubate lysate with phospho-VCL (Tyr822) antibody at 1:50 dilution overnight at 4°C .

  • Add protein A/G beads and incubate for 2-4 hours.

  • Wash extensively with lysis buffer.

  • Elute and analyze by Western blotting using total vinculin antibody.

  • Alternatively, immunoprecipitate with total vinculin antibody and probe with phospho-tyrosine antibody.

Immunofluorescence Protocol:

  • Culture cells on fibronectin-coated coverslips to promote focal adhesion formation.

  • Fix cells with 4% paraformaldehyde (avoid methanol fixation).

  • Permeabilize with 0.1% Triton X-100.

  • Block with 1% BSA in PBS.

  • Incubate with phospho-VCL (Tyr822) antibody at 1:100-1:200 dilution.

  • Co-stain with other focal adhesion markers (paxillin, FAK) for colocalization analysis .

  • Use appropriate fluorophore-conjugated secondary antibodies.

  • Mount and image using confocal microscopy.

How can phospho-VCL (Tyr822) be studied in the context of force-dependent cellular responses?

Studying phospho-VCL (Tyr822) in force-dependent responses requires specialized techniques:

  • Substrate Stiffness Variation: Culture cells on polyacrylamide gels of varying stiffness (1-100 kPa) coated with fibronectin, then quantify Tyr822 phosphorylation levels by immunoblotting or immunofluorescence.

  • Traction Force Microscopy: Embed fluorescent beads in flexible substrates to measure cellular forces while simultaneously detecting Tyr822 phosphorylation, allowing correlation between force generation and phosphorylation status.

  • FRET-based Tension Sensors: Similar to those used for vinculin conformation studies, FRET probes can be designed to monitor both tension across vinculin and its phosphorylation state .

  • Magnetic Twisting Cytometry: Apply localized force to integrins using magnetic beads while monitoring Tyr822 phosphorylation at the bead attachment sites.

  • Pharmacological Interventions: Use of cytoskeletal inhibitors such as Y-27632 (ROCK inhibitor) or blebbistatin (myosin II inhibitor) to modulate cellular contractility while monitoring Tyr822 phosphorylation .

  • Time-course Analysis: Following mechanical stimulation (e.g., stretch, shear stress), collect samples at multiple timepoints to establish the dynamics of Tyr822 phosphorylation in response to force.

  • Mutant Expression Studies: Compare cells expressing wild-type vinculin, Y822F, and Y822C mutants in their response to mechanical stimuli, focusing on differences in adhesion dynamics and force transmission .

Investigations should prioritize correlation between applied/generated forces and phosphorylation levels to establish mechanistic relationships.

What are common challenges when detecting vinculin Tyr822 phosphorylation and how can they be addressed?

ChallengePotential CausesSolutions
Low signal intensityRapid dephosphorylation during sample preparationIncrease phosphatase inhibitor concentration; keep samples on ice; use rapid lysis methods
High backgroundNon-specific antibody bindingUse 5% BSA for blocking; increase washing steps; reduce primary antibody concentration; include competing phospho-peptides for non-specific sites
Inconsistent resultsVariability in phosphorylation levelsStandardize cell culture conditions; synchronize cells; use positive controls (pervanadate treatment)
False negativesLow abundance of phosphorylated formEnrich phospho-proteins before detection; use tyrosine phosphatase inhibitors; immunoprecipitate before Western blotting
Cross-reactivityAntibody recognizing other phospho-tyrosine sitesValidate with Y822F mutants; use peptide competition assays; confirm with mass spectrometry
Focal adhesion disruptionSample processing destroying structuresUse in situ fixation methods; avoid harsh detergents; consider crosslinking before lysis

For particularly challenging samples, consider:

  • Sequential immunoprecipitation approaches

  • Phospho-enrichment using TiO₂ or immobilized metal affinity chromatography (IMAC)

  • Multiple antibody validation with different clones recognizing the same epitope

  • Correlation with functional assays (e.g., measuring focal adhesion turnover rates)

How can researchers effectively study the dynamics of vinculin Tyr822 phosphorylation in living cells?

Studying vinculin Tyr822 phosphorylation dynamics in living cells presents unique challenges but can be approached through:

  • Genetically Encoded Biosensors: Development of FRET-based sensors containing vinculin with flanking fluorescent proteins that respond to phosphorylation-induced conformational changes, similar to those used for studying vinculin conformation .

  • Phospho-specific Binding Domains: Utilizing SH2 domains that specifically recognize phosphorylated Tyr822, fused to fluorescent proteins for real-time visualization.

  • Fluorescence Recovery After Photobleaching (FRAP): Comparing recovery dynamics of wild-type versus Y822F or Y822C vinculin-GFP fusions to determine how phosphorylation affects mobility within focal adhesions .

  • Temporal Analysis: Following stimulation with growth factors or mechanical perturbation, fix cells at short intervals (30 seconds to 30 minutes) and immunostain for phospho-Tyr822 to create temporal maps of phosphorylation dynamics.

  • Correlative Light-Electron Microscopy: Combining immunofluorescence for phospho-Tyr822 with electron microscopy to precisely localize phosphorylated vinculin within the nanoscale architecture of focal adhesions.

  • Single-Molecule Tracking: Using quantum dots conjugated to Fab fragments against phospho-Tyr822 to track individual phosphorylated vinculin molecules in living cells.

  • Optogenetic Approaches: Developing light-controlled kinase systems to induce Tyr822 phosphorylation with precise spatial and temporal control while monitoring cellular responses.

How does vinculin Tyr822 phosphorylation compare with other focal adhesion protein modifications in mechanotransduction studies?

Vinculin Tyr822 phosphorylation occupies a distinct position within the focal adhesion phosphorylation hierarchy:

Focal Adhesion ProteinKey Phosphorylation SitePrimary FunctionMechanical ResponsivenessTemporal Dynamics
VinculinTyr822Force transmission; ligand binding regulationDirect force-dependent modificationIntermediate response (minutes)
FAKTyr397Activation; recruitment of signaling proteinsEarly mechanosensitive eventRapid response (seconds to minutes)
PaxillinTyr118Scaffold for vinculin recruitmentDownstream of FAK activationIntermediate response (minutes)
BNIP-2VariousScaffold for FA complexesModulates FA protein interactionsSustained effect on FA architecture

Unlike FAK phosphorylation at Tyr397, which serves as an early mechanosensing event, vinculin Tyr822 phosphorylation appears to function more as a force-transmission regulator . While paxillin phosphorylation at Tyr118 predominantly affects protein recruitment to focal adhesions, Tyr822 phosphorylation on vinculin more directly influences the protein's binding properties and conformational state .

Researchers should consider these differences when designing experiments:

  • For early mechanosensing events, FAK phosphorylation should be monitored

  • For force transmission effects, vinculin Tyr822 phosphorylation is more relevant

  • For comprehensive mechanotransduction studies, a time-course analysis of multiple phosphorylation events should be conducted

What considerations should researchers take when studying vinculin Tyr822 phosphorylation in different model systems?

When investigating vinculin Tyr822 phosphorylation across different model systems, researchers should consider:

Cell Type-Specific Considerations:

  • Fibroblasts: Typically display prominent focal adhesions with high levels of detectable vinculin; ideal for initial characterization studies.

  • Epithelial Cells: Consider both focal adhesions and adherens junctions, as vinculin localizes to both structures with potentially different phosphorylation patterns.

  • Endothelial Cells: May show different regulation patterns, particularly under fluid shear stress conditions; compare with S721 phosphorylation which is prominent in these cells .

  • Cancer Cells: May exhibit altered baseline phosphorylation due to dysregulated kinase activity; compare with Y822C mutant phenotypes observed in uterine cancer .

  • Cardiomyocytes: Consider costameric vinculin and its distinct regulation in muscle cells; may respond differently to mechanical stimuli .

Model System Considerations:

  • 2D vs. 3D Culture: Phosphorylation patterns may differ significantly; validate findings in both systems.

  • Animal Models: Ensure antibody cross-reactivity with the species being studied; consider developmental stage-specific regulation.

  • Patient Samples: May require specialized fixation protocols to preserve phosphorylation; consider disease-specific alterations.

Technical Adaptations:

  • Adjust lysis conditions based on cellular context (e.g., stronger detergents for muscle tissue)

  • Optimize stimulation conditions for each cell type (e.g., different ECM proteins, stiffness values)

  • Consider cell-specific phosphatase activity and adjust inhibitor cocktails accordingly

  • For tissues, implement antigen retrieval methods compatible with phospho-epitope preservation

How can researchers integrate vinculin Tyr822 phosphorylation data with other cellular signaling pathways?

Integrating vinculin Tyr822 phosphorylation data with broader signaling networks requires:

  • Pathway Analysis Approaches:

    • Perform phospho-proteomic analysis following modulation of Tyr822 phosphorylation

    • Use kinase inhibitor panels to identify upstream regulators

    • Employ phosphatase inhibitors to assess regulated dephosphorylation mechanisms

    • Correlate Tyr822 phosphorylation with activation of Rho GTPases and MAPK pathways

  • Multi-omics Integration:

    • Combine phospho-proteomic data with transcriptomic analysis to identify gene expression changes downstream of altered Tyr822 phosphorylation

    • Correlate with metabolomic data to understand bioenergetic consequences of altered focal adhesion dynamics

    • Integrate with interactome data to map modified protein-protein interactions

  • Systems Biology Approaches:

    • Develop computational models incorporating Tyr822 phosphorylation as a node in mechano-signaling networks

    • Perform sensitivity analysis to determine the relative importance of this modification

    • Use agent-based modeling to predict cellular behavior changes based on Tyr822 phosphorylation status

  • Cross-talk Analysis:

    • Investigate how Tyr822 phosphorylation interacts with other vinculin modifications, particularly S721 phosphorylation

    • Examine coordination with FAK-paxillin signaling pathway components

    • Study how BNIP-2 scaffolding function affects Tyr822 phosphorylation in the context of focal adhesion organization

  • Disease Relevance Integration:

    • Compare Tyr822 phosphorylation patterns between normal and pathological samples

    • Correlate with cancer cell behaviors when Y822C mutations are present

    • Investigate potential therapeutic approaches targeting pathways regulating Tyr822 phosphorylation

By systematically integrating these approaches, researchers can position vinculin Tyr822 phosphorylation within the broader cellular signaling landscape and better understand its role in normal physiology and disease states.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.